IC
XYL icon

Inscription Capital’s Xylem XYL Stock Holding History

Inscription Capital’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,196
Closed -$262K – 859
2026
Q1 		$262K Sell
2,196
-3,144
-59% -$412K 0.03% 525
2025
Q4 		$727K Buy
5,340
+198
+4% +$28.5K 0.07% 267
2025
Q3 		$758K Buy
5,142
+2,670
+108% +$370K 0.08% 246
2025
Q2 		$320K Buy
+2,472
New +$299K 0.05% 341

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Inscription Capital's XYL Position: Q2 2026 in Review

Inscription Capital sold out of Xylem (XYL) in Q2 2026, closing a stake of 2,196 shares — an estimated $262K sold.

Inscription Capital first reported a position in XYL in Q2 2025 and held it in 4 quarters. The position peaked at $758K in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Inscription Capital reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Inscription Capital sold 2,196 Xylem shares in Q2 2026, an estimated $262K.
  • Inscription Capital first reported a position in Xylem in Q2 2025 and held it in 4 quarters.
  • Inscription Capital's Xylem position peaked at $758K in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.